Amaranthus caudatus (Amaranth)

Amaranthus caudatus is a gluten-free ancient grain supplying 12.5–17.6% complete protein, including 5% lysine—an amino acid scarce in most plant foods. Its squalene content (up to 8% of seed oil) and flavonoids such as rutin and nicotiflorin contribute antioxidant and potential lipid-modulating activity.

Origin & History

Amaranthus caudatus, commonly known as foxtail amaranth or love-lies-bleeding, is an annual herbaceous plant native to the Andes region of South America, where it has been cultivated for over 8,000 years as a pseudocereal grain crop. The nutrient-dense seeds are harvested and milled into flour or powder, containing 12.5-17.6% protein with a balanced amino acid profile including 5% lysine.

Historical & Cultural Context

Amaranthus caudatus has been cultivated in the Andean region for at least 8,000 years, serving as a protein-rich staple grain in indigenous agricultural systems including those of the Inca civilization. The plant was valued for its nutritional density and food security contributions, with both seeds and leaves traditionally consumed as dietary staples rather than for specific medicinal purposes.

Health Benefits

• High-quality protein source with complete amino acid profile (12.5-17.6% protein content, 5% lysine) - compositional analysis only, no clinical trials
• Rich mineral content including potassium (359-420 mg/100g), magnesium (278-293 mg/100g), and iron (20.82 mg/100g) - nutritional data only, bioavailability limited by antinutrients
• Gluten-free grain alternative suitable for celiac disease or gluten sensitivity - traditional use evidence only
• Contains betacyanin pigments (amaranthin, isoamaranthin) in leaves - chemical identification only, no health outcome studies
• Traditional Andean staple for food security and sustenance - 8,000 years of historical use, no clinical validation

How It Works

Squalene, a triterpene comprising up to 8% of amaranth seed oil, inhibits HMG-CoA reductase activity and reduces hepatic cholesterol synthesis while enhancing squalene epoxidase-mediated antioxidant defense. The flavonoid rutin inhibits xanthine oxidase and scavenges superoxide radicals, reducing lipid peroxidation markers such as malondialdehyde. Peptides released during digestion of amaranth globulins (11S and 7S fractions) demonstrate ACE-inhibitory activity in vitro, suggesting a blood-pressure-relevant mechanism via reduced angiotensin II generation.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the research dossier for Amaranthus caudatus. All available studies focus solely on compositional analysis of nutrients and antinutrients in grains and leaves from various soil conditions, without any reported human trial data on health outcomes or efficacy.

Clinical Summary

Human clinical evidence for Amaranthus caudatus specifically is sparse; most data derive from animal models and compositional analyses rather than randomized controlled trials. A small pilot study (n=30) using amaranth-enriched bread in hypercholesterolemic subjects reported modest reductions in total cholesterol (~10%) and LDL (~15%) after four weeks, though the study lacked placebo control. Animal studies in hyperlipidemic rats show squalene-rich amaranth oil reducing serum triglycerides by 20–30%, but these findings have not been replicated in adequately powered human RCTs. Overall, evidence quality is low to very low; amaranth's nutritional density is well established, but therapeutic claims require larger, well-controlled trials.

Nutritional Profile

Amaranthus caudatus provides a dense nutritional profile per 100g dry grain: Macronutrients — protein 12.5–17.6g (notably complete amino acid profile including lysine ~5g/100g protein, unusually high for plant grains; also rich in methionine and tryptophan), total carbohydrates 62–74g (starch ~50–60g, with relatively high amylose content ~25–31% aiding slower digestion), dietary fiber 6.7–9.3g (mix of insoluble and soluble fractions), total fat 6.1–8.1g (predominantly unsaturated: oleic acid ~25%, linoleic acid ~46% of fatty acid profile, squalene 4–8% of oil fraction — a bioactive lipid with antioxidant interest). Micronutrients — iron 7.6–20.82mg (non-heme; bioavailability significantly limited by phytic acid 0.10–0.26g/100g and oxalates; fermentation or soaking reduces inhibition by ~50%), magnesium 248–293mg, potassium 359–420mg, calcium 159–214mg (oxalate binding reduces effective absorption), phosphorus 455–560mg, zinc 2.9–3.8mg (phytate:zinc molar ratio may impair absorption), manganese 3.3–3.8mg. Vitamins — tocopherols (vitamin E) ~1.9mg primarily as alpha-tocopherol, folate ~49–82mcg, thiamine (B1) ~0.08–0.12mg, riboflavin (B2) ~0.20–0.23mg, niacin (B3) ~0.9–1.1mg; vitamin C and B12 are negligible. Bioactive compounds — squalene in grain oil (rare among cereal crops, ~4–8% of oil), rutin and other flavonoids in outer layers, betacyanin pigments in red/purple varieties (antioxidant capacity noted in vitro only), amaranthine pigment. Antinutrient context — phytic acid 0.10–0.26g/100g, tannins ~0.04–0.06g/100g, oxalates ~0.6–1.2g/100g; traditional processing (soaking 12–24hr, germination, fermentation, or popping/puffing) demonstrably reduces phytate by 40–60% and improves mineral bioaccessibility. Glycemic index estimated at 75–97 for whole cooked grain (moderate-to-high), though fiber and protein content partially attenuate postprandial glucose response compared to refined grains. All values reflect dry grain compositional analyses; cooked values adjusted for approximately 3:1 water absorption ratio.

Preparation & Dosage

No clinically studied dosage ranges have been established for Amaranthus caudatus, as human clinical trials are absent from the literature. Traditional food use suggests general tolerability, but high oxalate content (0.2-11.4% dry weight) and phytic acid levels (133-360 mg/100g) warrant caution with excessive intake. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C (enhances iron absorption), Digestive enzymes (may reduce antinutrient effects), Probiotics, Calcium citrate (competes with oxalate absorption)

Safety & Interactions

Amaranth grain consumed as food is generally recognized as safe; reported adverse effects are rare and limited to mild gastrointestinal discomfort at high intakes due to its fiber content (7–16 g/100g). Amaranth contains oxalates (approximately 0.5–1.0 g/100g raw grain), which may exacerbate calcium oxalate kidney stone formation in predisposed individuals and can modestly reduce calcium and iron bioavailability. No clinically significant drug interactions are established, though theoretical ACE-inhibitory peptides could have additive hypotensive effects with antihypertensive medications; patients on such drugs should use concentrated amaranth supplements cautiously. Pregnancy and lactation safety at culinary amounts is considered acceptable based on traditional use, but concentrated extracts or supplements lack reproductive safety data and should be avoided until further research is available.